Explore more publications!
Djibouti Health Journal
Submit Press Release

Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 2, 2025

BioStem Technologies to Present at Two Upcoming Investor Conferences
September 2, 2025

BioStem Technologies to Present at Two Upcoming Investor Conferences

Indeterminate GlobeNewswire
PolarityBio Announces Launch of Expanded Access Treatment Protocol to Provide Continued Access to SkinTE® for Patients with Wagner 1 Diabetic Foot Ulcers
September 2, 2025

PolarityBio Announces Launch of Expanded Access Treatment Protocol to Provide Continued Access to SkinTE® for Patients with Wagner 1 Diabetic Foot Ulcers

Indeterminate GlobeNewswire
Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025

Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Indeterminate GlobeNewswire
Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025

Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Indeterminate GlobeNewswire
Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial
September 2, 2025

Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial

Indeterminate GlobeNewswire
PolyPid to Present at the 14th Meeting of the Israel Controlled Release Society Conference
September 2, 2025

PolyPid to Present at the 14th Meeting of the Israel Controlled Release Society Conference

Indeterminate GlobeNewswire
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
September 2, 2025

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
September 2, 2025

Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Indeterminate GlobeNewswire
Sotagliflozin Provides Consistent Relative Risk Reduction in Heart Failure and Major Cardiovascular Events Across All Age Ranges, Including Greater Than 75, in Data Presented at the European Society of Cardiology (ESC) 2025 Congress
September 2, 2025

Sotagliflozin Provides Consistent Relative Risk Reduction in Heart Failure and Major Cardiovascular Events Across All Age Ranges, Including Greater Than 75, in Data Presented at the European Society of Cardiology (ESC) 2025 Congress

Indeterminate GlobeNewswire
Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences
September 2, 2025

Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences

Indeterminate GlobeNewswire
Hydreight Technologies Signs Definitive Agreement to Acquire 5% Equity Stake in Perfect Scripts, LLC, with Option to Increase to 40%, and Establish Strategic Partnership
September 2, 2025

Hydreight Technologies Signs Definitive Agreement to Acquire 5% Equity Stake in Perfect Scripts, LLC, with Option to Increase to 40%, and Establish Strategic Partnership

Indeterminate GlobeNewswire
SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival
September 2, 2025

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

Indeterminate GlobeNewswire
First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter
September 2, 2025

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

Indeterminate GlobeNewswire
Candel Therapeutics Appoints Renowned Immunotherapy Pioneer Carl H. June, M.D., to Research Advisory Board
September 2, 2025

Candel Therapeutics Appoints Renowned Immunotherapy Pioneer Carl H. June, M.D., to Research Advisory Board

Indeterminate GlobeNewswire
STRATA Skin Sciences IP Portfolio Holds Exclusivity in Combination Therapies of Its XTRAC Excimer Laser with JAK Inhibitors, Systemic and Biologic Drugs, Bolstering Expansion into New Indications Like Vitiligo and Other Auto-Immune Skin Conditions
September 2, 2025

STRATA Skin Sciences IP Portfolio Holds Exclusivity in Combination Therapies of Its XTRAC Excimer Laser with JAK Inhibitors, Systemic and Biologic Drugs, Bolstering Expansion into New Indications Like Vitiligo and Other Auto-Immune Skin Conditions

Indeterminate GlobeNewswire
IMUNON to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025

IMUNON to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Indeterminate GlobeNewswire
Mainz Biomed Announces Registration of ColoAlert in the United Kingdom
September 2, 2025

Mainz Biomed Announces Registration of ColoAlert in the United Kingdom

Indeterminate GlobeNewswire
Nkarta to Participate in a September Investor Conference
September 2, 2025

Nkarta to Participate in a September Investor Conference

Indeterminate GlobeNewswire
Coag-Sense® PT/INR Monitoring System Approved for Patient Self-Testing in Europe
September 2, 2025

Coag-Sense® PT/INR Monitoring System Approved for Patient Self-Testing in Europe

Indeterminate GlobeNewswire
Step Pharma announces first participant dosed in a phase 1b clinical trial of dencatistat for essential thrombocythaemia
September 2, 2025

Step Pharma announces first participant dosed in a phase 1b clinical trial of dencatistat for essential thrombocythaemia

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions